PCN9 Modeling Lifetime Effectiveness of Denosumab Versus Placebo in Men With Castration Resistant Prostate Cancer (CRPC) at High Risk of Developing Bone Metastasis (BM)
Abstract
Authors
M. Lothgren G. Hechmati I. Jacobs Y. Qian J. Arellano